Delivra Health Brands (TSE:DHB)
:DHB
Want to see TSE:DHB full AI Analyst Report?
DHB Stock Chart & Stats
C$0.14
C$0.00(0.00%)
At close: 4:00 PM EST
C$0.14
C$0.00(0.00%)
Day’s Range― - ―
52-Week RangeC$0.13 - C$0.37
Previous CloseN/A
Volume20.60K
Average Volume (3M)26.13K
Market Cap
C$4.69M
Enterprise ValueC$3.41M
Total Cash (Recent Filing)C$3.23M
Total Debt (Recent Filing)C$2.26M
Price to Earnings (P/E)―
Beta1.71
Next Earnings
May 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding31,261,782
10 Day Avg. Volume58,945
30 Day Avg. Volume26,134
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)1.30
Price to Sales (P/S)0.41
P/FCF Ratio-7.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$0.60Price Target Upside328.57% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.01
Revenue Forecast (FY)C$14.97M
Bulls Say, Bears Say
Bulls Say
Healthy Gross MarginsSustained gross margins near 50% indicate durable product-level profitability typical of branded consumer health CPG. This margin profile gives room to invest in marketing, channel expansion, and R&D while absorbing input cost swings, supporting long-term margin sustainability.
Manageable LeverageModerate leverage with positive equity provides financial flexibility for a small issuer. Debt levels at roughly half of equity reduce refinancing and liquidity risk, enabling continued investment in commercialization and product development without immediate solvency pressure.
Historical Revenue ExpansionMulti-year top-line growth demonstrates product-market fit and successful commercialization in retail/CPG channels. For a consumer health business, historical expansion supports scale economics, distributor relationships, and brand recognition that can underpin future recurring sales.
Bears Say
Ongoing UnprofitabilityPersistent negative net margins and slight negative EBIT indicate the turnaround remains incomplete. Continued losses constrain retained earnings, increase reliance on external capital for growth, and mean shareholder returns depend on sustainable path to operating profitability.
Weak, Volatile Cash GenerationIntermittent cash generation and recent cash burn reduce financial flexibility for marketing and inventory investment. Volatile free cash flow raises probability of future financing needs, which can dilute shareholders or limit the company’s ability to execute long-term commercialization plans.
Recent Revenue Momentum CooledA recent decline in TTM revenue signals momentum loss after prior expansion. For a small CPG player, even modest top-line slippage can erode operating leverage, delay breakeven, and make margins more sensitive to fixed costs and promotional spend over the medium term.
Delivra Health Brands News
DHB FAQ
What was Delivra Health Brands’s price range in the past 12 months?
Delivra Health Brands lowest stock price was C$0.13 and its highest was C$0.37 in the past 12 months.
What is Delivra Health Brands’s market cap?
Delivra Health Brands’s market cap is C$4.69M.
When is Delivra Health Brands’s upcoming earnings report date?
Delivra Health Brands’s upcoming earnings report date is May 27, 2026 which is in 26 days.
How were Delivra Health Brands’s earnings last quarter?
Delivra Health Brands released its earnings results on Feb 27, 2026. The company reported -C$0.01 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.01.
Is Delivra Health Brands overvalued?
According to Wall Street analysts Delivra Health Brands’s price is currently Undervalued.
Does Delivra Health Brands pay dividends?
Delivra Health Brands does not currently pay dividends.
What is Delivra Health Brands’s EPS estimate?
Delivra Health Brands’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Delivra Health Brands have?
Delivra Health Brands has 31,261,782 shares outstanding.
What happened to Delivra Health Brands’s price movement after its last earnings report?
Delivra Health Brands reported an EPS of -C$0.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Delivra Health Brands?
Currently, no hedge funds are holding shares in TSE:DHB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Delivra Health Brands
Delivra Health Brands Inc. through its subsidiaries, provides lifestyle and wellness products to consumers and patients in regulated markets worldwide. The company is involved in selling of cannabis, liquid sleep shots, sleep powder packets, gummies, and pain relief creams. It offers its products under LivRelief, Dream Water, and LivRelief infused brand names. The company was formerly known as Harvest One Cannabis Inc. Delivra Health Brands Inc. is headquartered in Vancouver, Canada.
DHB Stock 12 Month Forecast
Average Price Target
C$0.60
▲(328.57% Upside)
Technical Analysis
Options Prices
Currently, No data available
---